Esketamine combined with dexmedetomidine
2025-SR-1088
Approved small_molecule active
Quick answer
Esketamine combined with dexmedetomidine for Dexmedetomidine is a Approved program (small_molecule) at First Tracks Biotherapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Dexmedetomidine
- Phase
- Approved
- Modality
- small_molecule
- Status
- active